CD177 and cancer: Using a gene-based strategy to ensure the continuous production of Nb1 in the TME, we showed that NRP-1 blockade using Nb1 resulted in a delayed outgrowth of MC38 tumors and consequently enhanced survival, thereby confirming the importance of NRP-1 as a cancer target.